Investor List:

Top Therapeutics Series A Investors in Canada (6)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Drug Delivery (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Robotics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Drug Delivery (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Hardware (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Health & Hospital Services (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Drug Delivery (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in Chemicals (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in EnergyTech (Series A), Investors in Therapeutics (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Chemicals (Series A), Investors in AI (Series A), Investors in Material Science (Series A), Investors in Semiconductors (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Semiconductors (Series B), Investors in Material Science (Series B), Investors in Chemicals (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Chemicals (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Samantha Tabone, Partner at Empath Ventures
Samantha Tabone
Sweet spot: $100K
Range: $50K - $250K
Investors in Canada, Investors in Australia, Investors in Europe, Investors in United Kingdom, Investors in United States
Photo of Soyoung Park, General Partner at 1004 Venture Partners
Soyoung Park
1004 Venture Partners·General Partner
Sweet spot: $500K
Range: $100K - $10.0M
Investors in South Korea, Investors in Japan, Investors in Europe, Investors in United Kingdom, Investors in Canada, Investors in United States
Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Generative Tech/AI (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Generative Tech/AI (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Generative Tech/AI (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Generative Tech/AI (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Robotics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Wellness & Fitness (Series B), Investors in Diagnostics (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Wellness & Fitness (Series B), Investors in Generative Tech/AI (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Series B), Investors in Robotics (Series B), Investors in Canada (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Female Investors (Other Lists), Investors in Diverse Investors (Other Lists)
Photo of Mack Luby, Associate at Mystic Ventures
Mack Luby
Mystic Ventures·Associate
Sweet spot: $250K
Range: $50K - $1M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Drug Delivery (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in AI (Seed), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Canada (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists)
Photo of Humayun H., Investor
Humayun H.
Investor
Sweet spot: $1M
Range: $100K - $10.0M
Investors in LatAm (Latin America), Investors in Mexico, Investors in Canada, Investors in United States, Investors in Asia, Investors in Europe
Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Consumer Internet (Seed), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Therapeutics (Seed), Investors in Real Estate/PropTech (Seed), Investors in Wellness & Fitness (Seed), Investors in Consumer Internet (Seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Series A), Investors in Robotics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Real Estate/PropTech (Series A), Investors in Consumer Internet (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Consumer Internet (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Real Estate/PropTech (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Consumer Internet (Series A), Investors in Robotics (Series A), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Pharmaceuticals (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in Real Estate/PropTech (Series B), Investors in Robotics (Series B), Investors in Consumer Internet (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Robotics (Series B), Investors in Canada (Other Lists), Investors in LatAm (Latin America) (Other Lists), Investors in London (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Get new data & insights delivered to your inbox